NCT00380822

Brief Summary

To investigate the efficacy and safety of miglitol in Japanese patients with type 2 diabetes that is insufficiently controlled diet alone.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

27 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 25, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 27, 2006

Completed
Last Updated

September 27, 2006

Status Verified

September 1, 2006

First QC Date

September 25, 2006

Last Update Submit

September 25, 2006

Conditions

Keywords

alpa-glucosidase inhibitor

Interventions

Eligibility Criteria

Age20 Years - 69 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Type2 diabetic patient on Dietary Therapy
  • Criteria for postprandial plasma glucose and HbA1c are met

You may not qualify if:

  • Type1 diabetes
  • Patients treated with antidiabetic drugs or Insulin

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (27)

Unknown Facility

Aichi, Japan

Location

Unknown Facility

Chiba, Japan

Location

Unknown Facility

Fukuoka, Japan

Location

Unknown Facility

Gunma, Japan

Location

Unknown Facility

Hiroshima, Japan

Location

Unknown Facility

Hyōgo, Japan

Location

Unknown Facility

Ibaraki, Japan

Location

Unknown Facility

Ishikawa, Japan

Location

Unknown Facility

Kumamoto, Japan

Location

Unknown Facility

Kyoto, Japan

Location

Unknown Facility

Mie, Japan

Location

Unknown Facility

Miyagi, Japan

Location

Unknown Facility

Nagasaki, Japan

Location

Unknown Facility

Niigata, Japan

Location

Unknown Facility

Numakunai, Japan

Location

Unknown Facility

Okayama, Japan

Location

Unknown Facility

Osaka, Japan

Location

Unknown Facility

Ōita, Japan

Location

Unknown Facility

Saga, Japan

Location

Unknown Facility

Saitama, Japan

Location

Unknown Facility

Shiga, Japan

Location

Unknown Facility

Shimane, Japan

Location

Unknown Facility

Shizuoka, Japan

Location

Unknown Facility

Tokyo, Japan

Location

Unknown Facility

Toyama, Japan

Location

Unknown Facility

Yamagata, Japan

Location

Unknown Facility

Yamaguchi, Japan

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

miglitol

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Clinical study Group, Clinical Development Dept.

    Sanwa Kagaku Kenkyusho Co., Ltd.

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

September 25, 2006

First Posted

September 27, 2006

Last Updated

September 27, 2006

Record last verified: 2006-09

Locations